UnitedHealth Group Incorporated (NYSE:UNH) Position Trimmed by Tandem Investment Advisors Inc.

Tandem Investment Advisors Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,567 shares of the healthcare conglomerate’s stock after selling 33 shares during the quarter. Tandem Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $825,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Daiwa Securities Group Inc. boosted its holdings in UnitedHealth Group by 5.4% during the fourth quarter. Daiwa Securities Group Inc. now owns 183,323 shares of the healthcare conglomerate’s stock worth $96,513,000 after buying an additional 9,359 shares in the last quarter. Archer Investment Corp lifted its position in shares of UnitedHealth Group by 4.3% in the 4th quarter. Archer Investment Corp now owns 2,593 shares of the healthcare conglomerate’s stock valued at $1,365,000 after acquiring an additional 106 shares in the last quarter. Telos Capital Management Inc. lifted its position in shares of UnitedHealth Group by 19.8% in the 4th quarter. Telos Capital Management Inc. now owns 1,601 shares of the healthcare conglomerate’s stock valued at $843,000 after acquiring an additional 265 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its position in shares of UnitedHealth Group by 181.5% in the 4th quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,467 shares of the healthcare conglomerate’s stock valued at $2,346,000 after acquiring an additional 2,880 shares in the last quarter. Finally, KLCM Advisors Inc. lifted its position in shares of UnitedHealth Group by 42.5% in the 4th quarter. KLCM Advisors Inc. now owns 4,010 shares of the healthcare conglomerate’s stock valued at $2,111,000 after acquiring an additional 1,196 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on UNH. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday. Truist Financial reiterated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Finally, Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $571.20.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $10.10 during midday trading on Wednesday, reaching $478.99. The stock had a trading volume of 8,753,188 shares, compared to its average volume of 4,466,714. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm’s fifty day simple moving average is $490.31 and its 200-day simple moving average is $515.63. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a market capitalization of $441.60 billion, a P/E ratio of 20.09, a PEG ratio of 1.22 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the business posted $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.57%. UnitedHealth Group’s dividend payout ratio is 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.